Literature DB >> 14462758

Cataracts in patients treated with triparanol.

R C LAUGHLIN, T F CAREY.   

Abstract

Entities:  

Keywords:  CATARACT/etiology; CHOLESTEROL/antagonists

Mesh：

Substances：

Year:  1962        PMID： 14462758     DOI： 10.1001/jama.1962.03050300059020a

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  16 in total

Review 1.  Squalene synthase inhibitors.

Authors:  V C Menys; P N Durrington
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

2.  THE ESTIMATION OF DESMOSTEROL AND CHOLESTEROL IN PLASMA.

Authors:  L G WHITBY; R G GOLD; E G KITCHIN; H A FLEMING
Journal:  Br Heart J       Date:  1964-03

3.  Triparanol-induced Cataract in Rats.

Authors:  L von Sallmann; P Grimes; E Collins
Journal:  Trans Am Ophthalmol Soc       Date:  1963

Review 4.  Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential.

Authors:  Valentine Charlton-Menys; Paul N Durrington
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 5.  Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors:  V Craig Jordan
Journal:  Endocr Relat Cancer       Date:  2014-05-06       Impact factor: 5.678

6.  Statins repress hedgehog signaling in medulloblastoma with no bone toxicities.

Authors:  Qianhai Fan; Tingting Gong; Chaonan Zheng; Jessica M Y Ng; Jianquan Chen; Cynthia Myers; Harvey Hensley; Tom Curran; Zeng-Jie Yang
Journal:  Oncogene       Date:  2021-03-01       Impact factor: 9.867

7.  Cataracts produced by triparanol. (MER-29).

Authors:  T J Kirby
Journal:  Trans Am Ophthalmol Soc       Date:  1967

Review 8.  The lipids in pathology of the eye.

Authors:  G L Feldman
Journal:  J Am Oil Chem Soc       Date:  1967-11       Impact factor: 1.849

Review 9.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

10.  Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.

Authors:  J A Tobert; G D Bell; J Birtwell; I James; W R Kukovetz; J S Pryor; A Buntinx; I B Holmes; Y S Chao; J A Bolognese
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.